313 related articles for article (PubMed ID: 34629)
1. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.
Lorenzi M; Karam JH; Tsalikian E; Bohannon NV; Gerich JE; Forsham PH
J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629
[TBL] [Abstract][Full Text] [Related]
2. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
3. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
Knudtzon J
Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
[TBL] [Abstract][Full Text] [Related]
4. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
Rizza RA; Cryer PE; Haymond MW; Gerich JE
J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
[TBL] [Abstract][Full Text] [Related]
5. The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man.
Walter RM; Dudl RJ; Palmer JP; Ensinck JW
J Clin Invest; 1974 Nov; 54(5):1214-20. PubMed ID: 4153713
[TBL] [Abstract][Full Text] [Related]
6. Adrenergic modulation of human pancreatic polypeptide (hPP) release.
Sive AA; Vinik AI; Levitt N
Gastroenterology; 1980 Oct; 79(4):665-72. PubMed ID: 6997131
[TBL] [Abstract][Full Text] [Related]
7. Elevation of plasma epinephrine concentrations inhibits proteolysis and leucine oxidation in man via beta-adrenergic mechanisms.
Kraenzlin ME; Keller U; Keller A; Thélin A; Arnaud MJ; Stauffacher W
J Clin Invest; 1989 Aug; 84(2):388-93. PubMed ID: 2569473
[TBL] [Abstract][Full Text] [Related]
8. [Influence of alpha or beta adrenergic antagonists on catecholamine dependent metabolic effects in pigs].
Brenner KV; Gürtler H
Acta Biol Med Ger; 1981; 40(12):1759-66. PubMed ID: 6125073
[TBL] [Abstract][Full Text] [Related]
9. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
[TBL] [Abstract][Full Text] [Related]
10. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
[TBL] [Abstract][Full Text] [Related]
11. Metabolic intervention in surgical patients: the effect of alpha- or beta-blockade on glucose and protein metabolism in surgical patients receiving total parenteral nutrition.
Shaw JH; Holdaway CM; Humberstone DA
Surgery; 1988 May; 103(5):520-5. PubMed ID: 2896394
[TBL] [Abstract][Full Text] [Related]
12. Epinephrine-induced insulin resistance in man.
Deibert DC; DeFronzo RA
J Clin Invest; 1980 Mar; 65(3):717-21. PubMed ID: 6243677
[TBL] [Abstract][Full Text] [Related]
13. [Effects of various beta-receptor blockers on metabolic and circulatory parameters during physical exertion].
Koebe P; Rost R; Reinke A; Nagel N; Merten U
Arzneimittelforschung; 1985; 35(2):522-9. PubMed ID: 2859861
[TBL] [Abstract][Full Text] [Related]
14. Effect of three beta-blockers with different pharmacological properties on metabolic, cardiovascular and hormonal response to insulin-induced hypoglycemia in normal subjects.
Ikegami H; Shima K; Tanaka A; Tahara Y; Hirota M; Kumahara Y
Med J Osaka Univ; 1984 Sep; 35(1-2):35-40. PubMed ID: 6152009
[No Abstract] [Full Text] [Related]
15. No effect of beta-adrenergic blockade on hypoglycaemic effect of glucagon-like peptide-1 (GLP-1) in normal subjects.
Toft-Nielsen M; Hvidberg A; Hilsted J; Dige-Petersen H; Holst JJ
Diabet Med; 1996 Jun; 13(6):544-8. PubMed ID: 8799658
[TBL] [Abstract][Full Text] [Related]
16. Lack of beta-adrenergic role for catecholamines in the development of hyperglycemia and ketonaemia following acute insulin withdrawal in type I diabetic patients.
Beylot M; Sautot G; Dechaud H; Cohen R; Riou JP; Serusclat P; Mornex R
Diabete Metab; 1985 Apr; 11(2):111-7. PubMed ID: 2989015
[TBL] [Abstract][Full Text] [Related]
17. [Consequences of the administration of alpha or beta drenolytic agents on the mobilization of plasma free fatty acids as induced by noradrenaline and isoprenaline in the dog].
Berlan M
C R Seances Soc Biol Fil; 1976 Oct; 170(3):672-9. PubMed ID: 10055
[TBL] [Abstract][Full Text] [Related]
18. Adrenoceptors mediating the cardiovascular and metabolic effects of alpha-methylnoradrenaline in humans.
Schäfers RF; Nürnberger J; Herrmann B; Wenzel RR; Philipp T; Michel MC
J Pharmacol Exp Ther; 1999 May; 289(2):918-25. PubMed ID: 10215671
[TBL] [Abstract][Full Text] [Related]
19. Adrenergic regulation of basal serum glucose, NEFA and insulin levels.
Gagliardino JJ; Bellone CF; Doria I; Sănchez JJ; Pereyra V
Horm Metab Res; 1970 Nov; 2(6):318-22. PubMed ID: 4398896
[No Abstract] [Full Text] [Related]
20. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
